- Biologická léčba hypercholesterolemie2017 | First Faculty of Medicine
- Role of phytosterols in the treatment of hypercholesterolaemia2005 | Faculty of Medicine in Hradec Králové
- Treatment of hypercholesterolemia in the Czech Republic - up to date2021 | First Faculty of Medicine
- Ezetimibe - simvastatin fixed combination in the treatment of hypercholesterolemia - combination therapy or monotherapy?2007 | First Faculty of Medicine
- Treating hypercholesterolaemia with evolocumab +12018 | First Faculty of Medicine
- Komentář k článku: Léčba hypercholesterolemie v primární prevenci2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Léčba hypercholesterolemie při selhání monoterapie: význam fixní kombinace simvastatinu s ezetimibem2012 | Third Faculty of Medicine
- The treatment of hypercholesterolemia by PCSK9 inhibitors2014 | Faculty of Medicine in Hradec Králové
- Diagnosis and treatment of hypercholesterolemia in childhood1999 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Lovastatin: new aspects of it´s effects in hypercholesterolemic patientsPublication without faculty affiliation
- Extracorporeal elimination of LDL-cholesterolin the treatment of hypercholesterolaemias : indications and methods1995 | First Faculty of Medicine
- Ezetimib - new type of combination therapy of hypercholesterolemia2004 | Second Faculty of Medicine
- Current trends in pharmacological therapy of the hypercholesterolemia2005 | Second Faculty of Medicine
- The management of hypercholesterolemia in general practicioners surgeries2004 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Clinical usage of immunoadrorptive LDL-apheresisPublication without faculty affiliation
- The role of functional food and nutraceuticals in therapy of hypercholesterolemia of hypercholesterolemia of hypercholesterolemia2017 | First Faculty of Medicine
- PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Dual inhibition - a new perspective of the treatment of hypercholesterolaemia2003 | First Faculty of Medicine
- Twou sources of cholesterol and dual inhibition - a new perspective in hyperlipidemia treatment2004 | First Faculty of Medicine
- Indication of PCSK9 inhibitors in the expert view of the CSAT2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- What does current dyslipidemia treatment look like in clinical practice?2016 | Faculty of Medicine in Pilsen
- Turn in hypercholesterolemia treatment - PCSK9 inhibitors. What we know about the alirocumab (product Praluent(R)) yet?2016 | First Faculty of Medicine
- The significance of noncholester sterols as novel risk factors for cardiovascular diseases2013 | First Faculty of Medicine
- Fixed combination of amlodipine and atorvastatin2015 | First Faculty of Medicine
- Fixed combination of atorvastatin and ezetimibe in the dyslipidemia treatment2020 | Faculty of Medicine in Pilsen
- Repatha - evolocumab, first in Europe registered inhibitors PCSK2015 | First Faculty of Medicine
- Evolokumab for the treatment of familial hypercholesterolaemia2017 | Faculty of Medicine in Hradec Králové
- PCSK-inhibitor in theory, in studies and in the real practice2019 | First Faculty of Medicine
- The commentary on the study: The efficacy of alicumab in patients with hypercholesterolaemia, depending on the type and dose of co-administered statin - a combined analysis of 8 clinical trials2017 | Faculty of Medicine in Hradec Králové